MAPT and Alzheimer disease: Therefore, despite not been considered initially, systematically screening AD risk factors for their capacity to modulate Tau toxicity and APP metabolism (in Drosophila and in cellular models) highlighted the core of the FA pathway for its potential involvement in the molecular mechanisms of AD pathogenesis (Fig. 3).